Point72 Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.1M | Buy |
2,591,596
+305,163
| +13% | +$4.01M | 0.07% | 295 |
|
|
2025
Q1 | $32.9M | Sell |
2,286,433
-1,140,166
| -33% | -$16.4M | 0.08% | 280 |
|
|
2024
Q4 | $57.4M | Buy |
3,426,599
+710,936
| +26% | +$11.9M | 0.13% | 180 |
|
|
2024
Q3 | $43.4M | Buy |
2,715,663
+953,659
| +54% | +$15.2M | 0.11% | 198 |
|
|
2024
Q2 | $15.9M | Sell |
1,762,004
-495,714
| -22% | -$4.48M | 0.04% | 396 |
|
|
2024
Q1 | $25.5M | Buy |
2,257,718
+417,236
| +23% | +$4.71M | 0.06% | 339 |
|
|
2023
Q4 | $14.7M | Hold |
1,840,482
| – | – | 0.04% | 474 |
|
|
2023
Q3 | $11.9M | Sell |
1,840,482
-170,906
| -8% | -$1.11M | 0.03% | 518 |
|
|
2023
Q2 | $12.5M | Buy |
2,011,388
+235,906
| +13% | +$1.46M | 0.04% | 464 |
|
|
2023
Q1 | $6.84M | Buy |
1,775,482
+1,695,782
| +2,128% | +$6.53M | 0.02% | 587 |
|
|
2022
Q4 | $247K | Sell |
79,700
-38,100
| -32% | -$118K | ﹤0.01% | 893 |
|
|
2022
Q3 | $474K | Sell |
117,800
-15,800
| -12% | -$63.6K | ﹤0.01% | 904 |
|
|
2022
Q2 | $651K | Sell |
133,600
-773,400
| -85% | -$3.77M | ﹤0.01% | 888 |
|
|
2022
Q1 | $8.14M | Sell |
907,000
-190,908
| -17% | -$1.71M | 0.03% | 523 |
|
|
2021
Q4 | $12.4M | Buy |
1,097,908
+795,708
| +263% | +$8.96M | 0.05% | 430 |
|
|
2021
Q3 | $5.05M | Buy |
302,200
+202,200
| +202% | +$3.38M | 0.02% | 617 |
|
|
2021
Q2 | $2.22M | Buy |
+100,000
| New | +$2.22M | 0.01% | 669 |
|